Cargando…

Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?

Fecal microbiota transplantation (FMT) has been reported to decrease the incidence of recurrent urinary tract infections (UTIs), presumably by restoring microbiome diversity and/or uropathogen competition. We report a 16-year-old female with recurrent UTIs caused by multidrug-resistant Klebsiella pn...

Descripción completa

Detalles Bibliográficos
Autores principales: Vendrik, Karuna E W, de Meij, Tim G J, Bökenkamp, Arend, Ooijevaar, Rogier E, Groenewegen, Bas, Hendrickx, Antoni P A, Terveer, Elisabeth M, Kuijper, Ed J, van Prehn, Joffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314704/
https://www.ncbi.nlm.nih.gov/pubmed/35899275
http://dx.doi.org/10.1093/ofid/ofac324
_version_ 1784754381181157376
author Vendrik, Karuna E W
de Meij, Tim G J
Bökenkamp, Arend
Ooijevaar, Rogier E
Groenewegen, Bas
Hendrickx, Antoni P A
Terveer, Elisabeth M
Kuijper, Ed J
van Prehn, Joffrey
author_facet Vendrik, Karuna E W
de Meij, Tim G J
Bökenkamp, Arend
Ooijevaar, Rogier E
Groenewegen, Bas
Hendrickx, Antoni P A
Terveer, Elisabeth M
Kuijper, Ed J
van Prehn, Joffrey
author_sort Vendrik, Karuna E W
collection PubMed
description Fecal microbiota transplantation (FMT) has been reported to decrease the incidence of recurrent urinary tract infections (UTIs), presumably by restoring microbiome diversity and/or uropathogen competition. We report a 16-year-old female with recurrent UTIs caused by multidrug-resistant Klebsiella pneumoniae, for which frequent intravenous broad-spectrum antibiotic treatment was necessary. The patient was treated with FMT from a well-screened healthy donor without multidrug-resistant bacteria in the feces. After FMT, she developed several UTIs with an antibiotic-susceptible Escherichia coli that could be treated orally. The uropathogenic E. coli could be cultured from donor feces, and whole genome sequencing confirmed donor-to-recipient transmission. Our observation should stimulate discussion on long-term follow-up of all infections after FMT and donor fecal screening for antibiotic-susceptible Enterobacterales.
format Online
Article
Text
id pubmed-9314704
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-93147042022-07-26 Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening? Vendrik, Karuna E W de Meij, Tim G J Bökenkamp, Arend Ooijevaar, Rogier E Groenewegen, Bas Hendrickx, Antoni P A Terveer, Elisabeth M Kuijper, Ed J van Prehn, Joffrey Open Forum Infect Dis Novel ID Cases Fecal microbiota transplantation (FMT) has been reported to decrease the incidence of recurrent urinary tract infections (UTIs), presumably by restoring microbiome diversity and/or uropathogen competition. We report a 16-year-old female with recurrent UTIs caused by multidrug-resistant Klebsiella pneumoniae, for which frequent intravenous broad-spectrum antibiotic treatment was necessary. The patient was treated with FMT from a well-screened healthy donor without multidrug-resistant bacteria in the feces. After FMT, she developed several UTIs with an antibiotic-susceptible Escherichia coli that could be treated orally. The uropathogenic E. coli could be cultured from donor feces, and whole genome sequencing confirmed donor-to-recipient transmission. Our observation should stimulate discussion on long-term follow-up of all infections after FMT and donor fecal screening for antibiotic-susceptible Enterobacterales. Oxford University Press 2022-06-29 /pmc/articles/PMC9314704/ /pubmed/35899275 http://dx.doi.org/10.1093/ofid/ofac324 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Novel ID Cases
Vendrik, Karuna E W
de Meij, Tim G J
Bökenkamp, Arend
Ooijevaar, Rogier E
Groenewegen, Bas
Hendrickx, Antoni P A
Terveer, Elisabeth M
Kuijper, Ed J
van Prehn, Joffrey
Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?
title Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?
title_full Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?
title_fullStr Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?
title_full_unstemmed Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?
title_short Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?
title_sort transmission of antibiotic-susceptible escherichia coli causing urinary tract infections in a fecal microbiota transplantation recipient: consequences for donor screening?
topic Novel ID Cases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314704/
https://www.ncbi.nlm.nih.gov/pubmed/35899275
http://dx.doi.org/10.1093/ofid/ofac324
work_keys_str_mv AT vendrikkarunaew transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening
AT demeijtimgj transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening
AT bokenkamparend transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening
AT ooijevaarrogiere transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening
AT groenewegenbas transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening
AT hendrickxantonipa transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening
AT terveerelisabethm transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening
AT kuijperedj transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening
AT vanprehnjoffrey transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening